CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making.
Saved in:
| Title: | CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making. |
|---|---|
| Authors: | Worst, Thomas S.1 (AUTHOR) thomas.worst@medma.uni-heidelberg.de, Weis, Cleo-Aron2 (AUTHOR), Stöhr, Robert3 (AUTHOR), Bertz, Simone3 (AUTHOR), Eckstein, Markus3 (AUTHOR), Otto, Wolfgang4 (AUTHOR), Breyer, Johannes4 (AUTHOR), Hartmann, Arndt3 (AUTHOR), Bolenz, Christian5 (AUTHOR), Wirtz, Ralph M.6,7 (AUTHOR), Erben, Philipp1 (AUTHOR) |
| Source: | Scientific Reports. 9/26/2018, Vol. 8 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
